With just one month to go, have you completed your risk evaluations? Make sure you are ready!
Articles filtered by tag
The EU Pilot for 2 Member States to gain simultaneous national scientific advice is launched on 1st February. Find out more here.
Two Months to Go – Human medicinal product licences to be reviewed for the presence of Nitrosamine Impurities
Nitrosamines, TOPRA, & Drug Development News are the focus for our Q4 Industry Insights
Global Harmonisation of Clinical Trials is the latest focus for our quarterly roundup of the regulatory landscape with news from EMA, FDA and ICH
Our latest Industry Insights focuses on Brexit and news from the regulators around the globe.
Our first Industry Insights of 2019 focuses on the latest regulatory developments and Brexit.
Jakob Sandersen reports on the exciting developments at Pharmaceutical Services ApS over the last 15 months.
The final report on the SME Day at EMA focuses on the Committee for Advanced Therapies, new Medical Devices Regulation and a Brexit update.
Part Two of the report from the SME Day at the EMA focuses on Marketing Authorisations and more.
Larissa Gould reports from the EMA in Canary Wharf on the latest developments.
Our latest industry update covers news about Brexit, from FDA, EMA and more.